Case Studies
Aurora Shares Hit Ten-Month Highs on Organigram Bid
LOS ANGELES – Shares of Aurora Cannabis Inc. (ACB) surged ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The Cannabis and Psychedelics industries closed out ...
Alberta Regulator Sides with Aurora, Dismisses Curaleaf’s ATM Challenge
EDMONTON – The Alberta Securities Commission (ASC) dismissed Curaleaf Holdings' ...
Tilray Brands Reports Fiscal Q1 2027 Financial Results
NEW YORK - LONDON – Tilray Brands Inc. reported that net revenue for the three months ended August 31, 2026, climbed 23% year-over-year to $257.1 million, setting a new record for the company's opening fiscal ...
DEA Opens Schedule III Registration Path for Medical Cannabis Operators
WASHINGTON – The Drug Enforcement Administration’s Diversion Control Division has launched the application process, making DEA Form 225 available to state-licensed medical Cannabis manufacturers, distributors, and analytical labs. Manufacturers cover cultivation, production, processing, packaging, labeling ...
LA Gives Delinquent Cannabis Operators One More Year
LOS ANGELES – The Los Angeles City Council voted Tuesday to delay tax-compliance restrictions that would have blocked more than 100 Cannabis businesses from renewing their licenses at year's end. The decision came down to ...
Canopy Growth Powers European Expansion with UK Entry
SMITHS FALLS – Canopy Growth Corp. announced that it will supply four Canadian-grown medical Cannabis flower strains for distribution in the United Kingdom, expanding its international Cannabis business into another European market. The products will ...
Canna Cabana Takes the Widest Lead Yet in Canadian Cannabis Retail
CALGARY – A Retailer Insights Report compiled by Rebel & Thorn, a media and marketing consultancy, shows Canna Cabana extending its position across Canadian Cannabis retail in Q3 2026. The findings span brand awareness, primary ...
Trulieve Earns Its Spot on the S&P Indices
TALLAHASSEE – Trulieve Cannabis Corp. announced that S&P Dow Jones Indices had added the company to the S&P Total Market Index, the S&P Completion Index, and their respective health care sub-indices – S&P TMI Health Care and ...
GTI Bets on Its Own Stock, Again
CHICAGO – Green Thumb Industries Inc. announced that its board of directors had authorized a $50 million share repurchase program – the company's third consecutive buyback initiative since 2023. Under the new program, Green Thumb ...
Tilray Brands Reports Fiscal Q1 2027 Financial Results
NEW YORK - LONDON – Tilray Brands Inc. reported that net revenue for the three months ended August 31, 2026, climbed 23% year-over-year to $257.1 million, setting a new record for the company's opening fiscal ...
DEA Opens Schedule III Registration Path for Medical Cannabis Operators
WASHINGTON – The Drug Enforcement Administration’s Diversion Control Division has launched the application process, making DEA Form 225 available to state-licensed medical Cannabis manufacturers, distributors, and analytical labs. Manufacturers cover cultivation, production, processing, packaging, labeling ...
LA Gives Delinquent Cannabis Operators One More Year
LOS ANGELES – The Los Angeles City Council voted Tuesday to delay tax-compliance restrictions that would have blocked more than 100 Cannabis businesses from renewing their licenses at year's end. The decision came down to ...
Trulieve Secures $140M in Senior Notes
TALLAHASSEE – Trulieve Cannabis Corp. wrapped up a $140 million private placement of 10.5% senior secured notes, tapping into robust investor appetite to fuel its operational push. The deal, upsized from initial plans, comes just ...
🚨🚨 BREAKING: TRUMP RESCHEDULES CANNABIS 🚨🚨
WASHINGTON, D.C. –After months of speculation, President Trump Issues Executive Order Directing Federal Rescheduling of Cannabis to Schedule III President Donald Trump has signed an executive order directing federal agencies to complete the rescheduling of ...
Czech Republic Approves Psilocybin Therapy Guidelines for 2026
PRAGUE – The Czech Republic has taken a measured step toward integrating psychedelic-assisted therapy into its healthcare system, approving detailed rules that will permit the controlled use of psilocybin for select patients beginning in January ...
MSOS ETF Rally Hints at Bigger Gains Ahead, Zuanic Report Finds
LOS ANGELES – A recent report from equity research firm Zuanic & Associates outlines substantial financial gains for U.S. MSOs if federal regulators shift Cannabis to Schedule III status, with savings potentially exceeding hundreds of ...
Organigram Reports Q4 2025 Financial and Full Fiscal Year Results
TORONTO – Organigram Global Inc. released its record Q4 and fiscal 2025 results, showing substantial gains in revenue and profitability metrics despite a quarterly net loss tied to one-time charges. For the fourth quarter, gross ...
The Supreme Court Declines to Resolve Federal Cannabis Prohibition—And the Silence Speaks Volumes
WASHINGTON, D.C. – In its December Orders List, the U.S. Supreme Court declined to hear a case that many hoped would finally force a reckoning between federal Cannabis prohibition and state-legal markets. By declining review, ...
Canopy Growth Acquires MTL Cannabis in Bid to Ramp Up Medical Sales
SMITHS FALLS – Canopy Growth Corp., a major player in the Canadian Cannabis sector, has signed a definitive agreement to purchase MTL Cannabis Corp. in a cash-and-stock transaction worth about $125 million on a fully ...
Trump Sets Plans for Cannabis Reclassification Executive Order
WASHINGTON – President Donald Trump is set to direct federal agencies to reclassify Cannabis from its current Schedule I status to Schedule III under the Controlled Substances Act, a step that would align federal oversight ...
Mid-Cap Cannabis Operators Face Liquidity Pressures Despite Solid Leverage, Viridian Report Finds
LOS ANGELES – Public Cannabis companies with $25-100 million market values are navigating a patchwork of financial strengths and vulnerabilities, according to the latest Weekly Credit Report from Viridian Capital Advisors. It tracks eight U.S.-based ...
Ascend Wellness Partners with Cannabis Advocate for New Dispensary in New Jersey
NEW YORK – Ascend Wellness Holdings Inc. disclosed a partnership with Mister Jones LLC and industry advocate Lerone Jones to launch a retail dispensary in Little Falls, NJ. The arrangement, one of the initial deals ...
Grown Rogue Claims Ground in Minnesota
MINNEAPOLIS – Grown Rogue International Inc., a Сannabis MSO focused on premium flower, has signed a long-term lease for a 109,000-square-foot facility in Fridley, just north of Minneapolis, positioning the company to produce for the ...
New Mexico Speeds Up Psilocybin Therapy Access
SANTA FE – State health leaders in New Mexico outlined plans this week to open a regulated psilocybin therapy program by the close of 2026, advancing the timeline a full year from the original statutory ...
Stiiizy Expands California Retail Network Buying 12 Gold Flora Outlets
LOS ANGELES – Stiiizy, the dominant player in California's Cannabis retail, has taken control of 12 former Gold Flora dispensaries in a $25 million court-approved transaction, marking a key step in the state's ongoing industry ...
Cronos Targets Europe Through Dutch Cannabis Leader Acquisition
TORONTO – Cronos Group Inc. has agreed to buy CanAdelaar B.V., the top supplier in the Netherlands' controlled adult-use Cannabis program, for $67 million upfront plus performance incentives. The move marks Cronos's first major step ...
Craft Cannabis Market Projects Steady Climb to $12.3B by 2031
LOS ANGELES – Small-scale producers in the Cannabis industry are gaining ground as buyers turn toward premium, handcrafted options, with the craft segment expected to double in value over the next five years. A report ...
FDA Signals Shift to Single Phase 3 Trials for Drug Approvals, Opening Door for Faster Psychedelic Therapies
LOS ANGELES – The Food and Drug Administration is preparing to overhaul its evidence requirements for new drug approvals, making a single well-designed Phase 3 trial the standard rather than the exception. This adjustment, outlined ...
Trulieve Clears $368M Debt with Full Redemption of Senior Notes
TALLAHASSEE – Trulieve Cannabis Corp. wrapped up the buyback of its entire $368 million stack of 8% senior secured notes set to mature in 2026, handing over about $373 million in cash to cover the ...
OPINION: MJBizCon25 Review: The Race To Be Second
LAS VEGAS- Gosh… the MJBizCon I attended was awesome — genuinely one of the best and most productive ones I’ve ever been to — which is why I was so surprised to see how much ...
CRS Reveals Hemp Ban Enforcement Hurdles
WASHINGTON – The Congressional Research Service (CRS) has highlighted gaps in the federal government's plans to enforce the upcoming ban on intoxicating hemp products, raising questions about the practical reach of the law amid the ...
Federal Hemp Overhaul Threatens Cannabis Seed Trade, Sparking Breeder Backlash
LOS ANGELES – A tucked-away clause in last month's federal spending package has upended the rules for Cannabis seeds, thrusting the U.S. genetics sector into uncertainty and prompting warnings from cultivators that prized strains could ...
CMI Projects Double-Digit Expansion for Cannabis Testing Market
LOS ANGELES – A recent analysis from Custom Market Insights (CMI) forecasts the global Cannabis testing market to climb from $2.13 billion in 2025 to $11.15 billion by 2034, powered by a CAGR of 18%. ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past fortnight delivered a surge of momentum across the U.S. Cannabis and Psychedelics sectors, where federal signals on coverage and equity met bold state actions on access and licensing. Operators navigated ...
Psychedelics Advance in Federal Arena as Trials and Policies Align
LOS ANGELES – Federal health officials under the Trump administration have begun to signal stronger backing for psychedelic therapies, setting the stage for possible FDA approvals of MDMA and psilocybin treatments within the next 18 ...
RESPECT: House Lawmakers Introduce Cannabis Equity Resolution
WASHINGTON – A group of eight House lawmakers, led by members of the Congressional Cannabis Caucus, filed a resolution aimed at bolstering fair access to the burgeoning Cannabis sector for communities long sidelined by federal ...
Bipartisan Measure Targets Barriers to Psychedelic Therapies for Terminal Patients
WASHINGTON – A group of House and Senate lawmakers from both parties unveiled legislation to permit physicians to deliver Schedule I substances, including MDMA and psilocybin, to individuals grappling with terminal illnesses or severe mental ...
